and families by helping doctors understand more about how a once-weekly higher
dose of carfilzomib may work in patients with multiple myeloma.
9. Are There Plans for Further Studies?
If more clinical studies are done, they may be listed on public websites, such as
those below. Search for study medicine name carfilzomib (Kyprolis®) on the
websites below.
10. Where Can I Find More Information About This Study?
To find out more about this study, check these websites:
 www.clinicaltrials.gov. Use the study identifier NCT02412878
 www.clinicaltrialsregister.eu. Use the study identifier 2014-005325-12
 If you participated in the study and have questions about the study results, the
doctor or staff at your study site may be able to answer them.
10